Literature DB >> 12297807

The importance of glycerin-containing negative control tests in allergy research studies that use intradermal skin tests.

David S Hurst1, Bruce R Gordon, John H Krouse.   

Abstract

OBJECTIVE: We sought to assess skin whealing with glycerin-containing control injections for intradermal skin tests.
DESIGN: Observational.
METHODS: Wheal sizes were measured at 0, 10, and 15 minutes after intradermal injection of 0.01 and 0.02 mL of phenolated normal saline and 0.5% and 5% concentrations of glycerin in the same quantity of phenolated saline.
RESULTS: Intradermal injection of 0.01 mL of phenolated saline produced an average 4.9-mm wheal, which expanded to 5.2 mm at 10 minutes and to 6.0 mm at 15 minutes. Intradermal injection of 0.02 mL of phenolated saline produced a 6.4-mm wheal, which expanded to 7.0 mm at 10 minutes and 8.0 mm at 15 minutes. The addition of glycerin produced proportionally larger wheals.
CONCLUSIONS: Because glycerin increases whealing beyond that with phenolated saline, skin tests containing glycerin must be compared with glycerin-containing negative controls. Intradermal skin tests that fail to compare findings in this manner contain an inherent methodologic flaw and are uninterpretable.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12297807     DOI: 10.1067/mhn.2002.127890

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  2 in total

1.  Intradermal Testing Doubles Identification of Allergy among 110 Immunotherapy-Responsive Patients with Eustachian Tube Dysfunction.

Authors:  David S Hurst; Bruce R Gordon; Alan B McDaniel; Dennis S Poe
Journal:  Diagnostics (Basel)       Date:  2021-04-24

2.  Clinical Relevance and Advantages of Intradermal Test Results in 371 Patients with Allergic Rhinitis, Asthma and/or Otitis Media with Effusion.

Authors:  David S Hurst; Alan B McDaniel
Journal:  Cells       Date:  2021-11-18       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.